Olfaction in Parkin heterozygotes and compound heterozygotes: The CORE-PD study

R. N. Alcalay, A. Siderowf, R. Ottman, E. Caccappolo, H. Mejia-Santana, M. X. Tang, L. Rosado, E. Louis, D. Ruiz, C. Waters, S. Fahn, L. Cote, S. Frucht, B. Ford, M. Orbe-Reilly, B. Ross, M. Verbitsky, S. Kisselev, C. Comella, A. ColcherD. Jennings, M. Nance, S. Bressman, W. K. Scott, C. Tanner, S. Mickel, M. Rezak, K. E. Novak, J. H. Friedman, R. Pfeiffer, L. Marsh, B. Hiner, L. N. Clark, K. Marder

Research output: Contribution to journalArticle

33 Scopus citations

Abstract

Background: While Parkinson disease (PD) is consistently associated with impaired olfaction, one study reported better olfaction among Parkin mutation carriers than noncarriers. Whether olfaction differs between Parkin mutation heterozygotes and carriers of 2 Parkin mutations (compound heterozygotes) is unknown. OBJECTIVE:: To assess the relationship between Parkin genotype and olfaction in PD probands and their unaffected relatives. Methods: We administered the University of Pennsylvania Smell Identification Test (UPSIT) to 44 probands in the Consortium on Risk for Early-Onset Parkinson Disease study with PD onset ≤50 years (10 Parkin mutation heterozygotes, 9 compound heterozygotes, 25 noncarriers) and 80 of their family members (18 heterozygotes, 2 compound heterozygotes, 60 noncarriers). In the probands, linear regression was used to assess the association between UPSIT score (outcome) and Parkin genotype (predictor), adjusting for covariates. Among family members without PD, we compared UPSIT performance in heterozygotes vs noncarriers using generalized estimating equations, adjusting for family membership, age, gender, and smoking. Results: Among probands with PD, compound heterozygotes had higher UPSIT scores (31.9) than heterozygotes (20.1) or noncarriers (19.9) (p < 0.001). These differences persisted after adjustment for age, gender, disease duration, and smoking. Among relatives without PD, UPSIT performance was similar in heterozygotes (32.5) vs noncarriers (32.4), and better than in heterozygotes with PD (p = 0.001). Conclusion: Olfaction is significantly reduced among Parkin mutation heterozygotes with PD but not among their heterozygous relatives without PD. Compound heterozygotes with PD have olfaction within the normal range. Further research is required to assess whether these findings reflect different neuropathology in Parkin mutation heterozygotes and compound heterozygotes.

Original languageEnglish (US)
Pages (from-to)319-326
Number of pages8
JournalNeurology
Volume76
Issue number4
DOIs
StatePublished - Jan 25 2011

    Fingerprint

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Alcalay, R. N., Siderowf, A., Ottman, R., Caccappolo, E., Mejia-Santana, H., Tang, M. X., Rosado, L., Louis, E., Ruiz, D., Waters, C., Fahn, S., Cote, L., Frucht, S., Ford, B., Orbe-Reilly, M., Ross, B., Verbitsky, M., Kisselev, S., Comella, C., ... Marder, K. (2011). Olfaction in Parkin heterozygotes and compound heterozygotes: The CORE-PD study. Neurology, 76(4), 319-326. https://doi.org/10.1212/WNL.0b013e31820882aa